Human Intestinal Transporter Database: QSAR Modeling and Virtual Profiling of Drug Uptake, Efflux and Interactions

被引:64
作者
Sedykh, Alexander [1 ]
Fourches, Denis [1 ]
Duan, Jianmin [2 ]
Hucke, Oliver [3 ]
Garneau, Michel [2 ]
Zhu, Hao [1 ]
Bonneau, Pierre [3 ]
Tropsha, Alexander [1 ]
机构
[1] Univ N Carolina, Lab Mol Modeling, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA
[2] Boehringer Ingelheim Ltd, Dept Biol Sci, R&D, Laval, PQ H7S 2G5, Canada
[3] Boehringer Ingelheim Ltd, Dept Chem, R&D, Laval, PQ H7S 2G5, Canada
关键词
ADMET; drug transport; efflux; membrane transport proteins; permeability; COMPREHENSIVE DATABASE; MEMBRANE TRANSPORTERS; PREDICTION; BINDING; INHIBITION; PYRROLOPYRIMIDINES; PHARMACOKINETICS; IDENTIFICATION; ABSORPTION; DISCOVERY;
D O I
10.1007/s11095-012-0935-x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Membrane transporters mediate many biological effects of chemicals and play a major role in pharmacokinetics and drug resistance. The selection of viable drug candidates among biologically active compounds requires the assessment of their transporter interaction profiles. Using public sources, we have assembled and curated the largest, to our knowledge, human intestinal transporter database (> 5,000 interaction entries for > 3,700 molecules). This data was used to develop thoroughly validated classification Quantitative Structure-Activity Relationship (QSAR) models of transport and/or inhibition of several major transporters including MDR1, BCRP, MRP1-4, PEPT1, ASBT, OATP2B1, OCT1, and MCT1. QSAR models have been developed with advanced machine learning techniques such as Support Vector Machines, Random Forest, and k Nearest Neighbors using Dragon and MOE chemical descriptors. These models afforded high external prediction accuracies of 71-100% estimated by 5-fold external validation, and showed hit retrieval rates with up to 20-fold enrichment in the virtual screening of DrugBank compounds. The compendium of predictive QSAR models developed in this study can be used for virtual profiling of drug candidates and/or environmental agents with the optimal transporter profiles.
引用
收藏
页码:996 / 1007
页数:12
相关论文
共 45 条
[41]   Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding [J].
Vig, Balvinder S. ;
Stouch, Terry R. ;
Timoszyk, Julita K. ;
Quan, Yong ;
Wall, Doris A. ;
Smith, Ronald L. ;
Faria, Teresa N. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (12) :3636-3644
[42]   Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors [J].
Weiss, Johanna ;
Theile, Dirk ;
Ketabi-Kiyanvash, Nahal ;
Lindenmaier, Heike ;
Haefeli, Walter Emil .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (03) :340-344
[43]  
Yee SW, 2010, PHARMACOGENOMICS, V11, P475, DOI [10.2217/pgs.10.22, 10.2217/PGS.10.22]
[44]   Support vector machine and pharmacophore-based prediction models of multidrug-resistance protein 2 (MRP2) inhibitors [J].
Zhang, Hui ;
Xiang, Ming-Li ;
Zhao, Ying-Lan ;
Wei, Yu-Quan ;
Yang, Sheng-Yong .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 36 (4-5) :451-457
[45]   Computational Models for Drug Inhibition of the Human Apical Sodium-Dependent Bile Acid Transporter [J].
Zheng, Xiaowan ;
Ekins, Sean ;
Raufman, Jean-Pierre ;
Polli, James E. .
MOLECULAR PHARMACEUTICS, 2009, 6 (05) :1591-1603